U-BLRX

Q:BLRX - BIOLINE RX LTD SPON ADR EACH REP 600 ORD SHS (P/S) - https://www.biolinerx.com

23:53:41 EST

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
BLRX - Q	5.0	2.80	·	3.25	0.1	2.98	+0.06	2.1	4.9	13	59	2.92 2.99 2.92	7.7699 2.3001	18:20:13	Nov 24	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Down -- UPC Restricted: No

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 59

More trades...

Time ET	Ex	Price	Change	Volume
18:20:13	Q	2.98	0.06	1
16:10:04	Q	2.98	0.06	1
16:04:10	Q	2.98	0.06	1
16:00:02	Q	2.98	0.06	113
15:59:00	Q	2.97	0.05	12
15:47:37	Q	2.934	0.014	1
15:29:42	Q	2.99	0.07	34
15:27:18	Q	2.955	0.035	334
14:06:55	Q	2.99	0.07	1,152
13:52:01	Q	2.955	0.035	13

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2025-11-24 07:00	U:BLRX	News Release200	BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
2025-11-18 07:00	U:BLRX	News Release200	BioLineRx to Report Third Quarter 2025 Results on November 24, 2025
2025-11-17 07:00	U:BLRX	News Release200	BioLineRx Announces Receipt of USPTO Notice of Allowance for Key Patent Covering GLIX1 for Treating a Broad Range of Cancer Types
2025-09-29 07:00	U:BLRX	News Release200	BioLineRx Ltd. and Hemispherian AS Establish Joint Venture to Develop GLIX1, a First-in-Class, Oral, Small Molecule Targeting DNA Damage Response in Glioblastoma and Other Cancers
2025-08-14 07:00	U:BLRX	News Release200	BioLineRx Reports Second Quarter 2025 Financial Results and Provides Corporate Update
2025-08-07 07:00	U:BLRX	News Release200	BioLineRx to Report Second Quarter 2025 Results on August 14, 2025
2025-05-27 07:00	U:BLRX	News Release200	BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate Update
2025-05-20 07:00	U:BLRX	News Release200	BioLineRx to Report First Quarter 2025 Results on May 27, 2025
2025-03-31 07:00	U:BLRX	News Release200	BioLineRx Reports 2024 Financial Results and Provides Corporate Update

Date ET

Symbol

Type

Headline

2025-11-24 07:00

U:BLRX

News Release

BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update

2025-11-18 07:00

U:BLRX

News Release

BioLineRx to Report Third Quarter 2025 Results on November 24, 2025